Dimitrios Karagiannis Ilias Georgalas Ioannis Ladas Parikakis Eustratios Panagiotis Mitropoulos
Clin Interv Aging
2009;4:63-5.
idiopathic juxtafoveal retinal telangiectasis ranibizumab subretinal neovascularization
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/19503767/
Antibodies, Monoclonal / administration & dosage Retinal Neovascularization / drug therapy Telangiectasis Vitreous Body
Antibodies, Monoclonal / administration & dosage Retinal Neovascularization / drug therapy Telangiectasis Vitreous Body Case Reports Aged Antibodies, Monoclonal, Humanized Female Greece Humans Ranibizumab Retina / physiopathology Retinal Neovascularization / physiopathology Treatment Outcome Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Ranibizumab
PMC2685226
19503767
A case of subretinal neovascularization treated with intravitreal ranibizumab in a patient with idiopathic juxtafoveal retinal telangiectasis
2009